fruquintinib
Showing 26 - 42 of 42
Metastatic Colorectal Cancer Trial in Shanghai (Stereotactic Ablative Radiotherapy (SABR), Fruquintinib, Tislelizumab)
Recruiting
- Metastatic Colorectal Cancer
- Stereotactic Ablative Radiotherapy (SABR)
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 23, 2021
Drug Drug Interaction Trial in Cypress (Fruquintinib, Itraconazole, Rifampin)
Completed
- Drug Drug Interaction
- Fruquintinib
- +2 more
-
Cypress, CaliforniaWCCT
Jun 16, 2021
Metastatic NSCLC Trial in Shanghai (GB226, Fruquintinib)
Recruiting
- Metastatic Non-small Cell Lung Cancer
- GB226
- Fruquintinib
-
Shanghai, Shanghai, ChinaShanghai chest hospital
Mar 2, 2021
Metastatic Colorectal Cancer Trial in Harbin (Geptanolimab Injection, Fruquintinib)
Recruiting
- Metastatic Colorectal Cancer
- Geptanolimab Injection
- Fruquintinib
-
Harbin, Heilongjiang, ChinaHarbin Medical University Cancer Hospital
Feb 8, 2021
Colorectal Cancer Trial in China (fruquintinib, )
Completed
- Colorectal Cancer
- fruquintinib
- placebo
-
Beijing, Beijing, China
- +4 more
Jun 12, 2020
Food Effect of Fruquintinib in Health Subjects Trial in Shanghai (fruquintinib)
Completed
- Food Effect of Fruquintinib in Health Subjects
- fruquintinib
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
Feb 13, 2020
Tumor Trial in Shanghai (Fruquintinib)
Completed
- Tumor
- Fruquintinib
-
Shanghai, Shanghai, ChinaFudan University Cancer Center
Feb 13, 2020
Healthy Trial in Nanjing (fruquintinib)
Completed
- Healthy
- fruquintinib
-
Nanjing, Jiangsu, ChinaJiangsu Province Hospital
Feb 12, 2020
Colorectal Cancer Trial in Guangzhou, Shanghai (fruquintinib)
Completed
- Colorectal Cancer
- fruquintinib
-
Guangzhou, Guangdong, China
- +1 more
Feb 13, 2020
Metastatic Colorectal Cancer, Metastatic Colon Cancer Trial in Worldwide (Fruquintinib, Placebo)
Active, not recruiting
- Metastatic Colorectal Cancer
- Metastatic Colon Cancer
- Fruquintinib
- Placebo
-
Phoenix, Arizona
- +152 more
Mar 10, 2022
Metastasis Colorectal Cancer Trial in Beijing (fruquintinib, Sintilimab)
Unknown status
- Metastasis Colorectal Cancer
- fruquintinib
- Sintilimab
-
Beijing, ChinaChina PLAGH
Nov 25, 2019
Lung Cancer Trial in Guangzhou (Fruquintinib)
Withdrawn
- Lung Cancer
- Fruquintinib
-
Guangzhou, Guangdong, ChinaGuangdong General Hospital
Nov 17, 2019
NSCLC Trial in China (Fruquintinib, Placebo)
Completed
- Non-small Cell Lung Cancer
- Fruquintinib
- Placebo
-
Beijing, Beijing, China
- +11 more
Feb 12, 2020
Colorectal Cancer Trial in China (fruquintinib, )
Completed
- Colorectal Cancer
- fruquintinib
- placebo
-
Hefei, Anhui, China
- +14 more
Feb 13, 2020
Biliary Tract Adenocarcinoma Trial in China (Fruquintinib)
Unknown status
- Biliary Tract Adenocarcinoma
- Fruquintinib
-
Beijing, Beijing, China
- +6 more
Nov 6, 2019
NSCLC Trial in China (Fruquintinib, Placebo)
Completed
- NSCLC
- Fruquintinib
- Placebo
-
Beijing, Beijing, China
- +10 more
Feb 11, 2019